Ex Parte HillDownload PDFPatent Trial and Appeal BoardAug 22, 201713086519 (P.T.A.B. Aug. 22, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/086,519 04/14/2011 Gerard J. Hill P0025563.07/LG10126 4342 27581 7590 Medtronic, Inc. (CRDM) 710 MEDTRONIC PARKWAY NE MS: LC340 Legal Patents MINNEAPOLIS, MN 55432-9924 EXAMINER GHAND, JENNIFER LEIGH-STEWAR ART UNIT PAPER NUMBER 3766 NOTIFICATION DATE DELIVERY MODE 08/24/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): medtronic_crdm_docketing @ c ardinal-ip .com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte GERARD J. HILL Appeal 2016-006291 Application 13/086,5191 Technology Center 3700 Before DONALD E. ADAMS, RACHEL H. TOWNSEND, and DEVON ZASTROW NEWMAN, Administrative Patent Judges. TOWNSEND, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134 involving claims to an implantable medical device system, which have been rejected as obvious. We have jurisdiction under 35 U.S.C. § 6(b). We reverse. STATEMENT OF THE CASE “A wide variety of implantable medical devices ... are available for monitoring physiological conditions and/or delivering therapies.” (Spec. 1.) Although these devices are often coupled to medical leads which carry sensors, leadless devices have also been described where the sensors are in 1 Appellant identifies the Real Party in Interest as Medtronic, Inc. (Appeal Br. 3.) Appeal 2016-006291 Application 13/086,519 the housing of the device. (Id.) The function of implantable medical devices and patient care “may be enhanced by including sensors distributed to body locations that are remote from the [device].” (Id. at 2.) However, having a physical connection between the device and the sensors could “be cumbersome, highly invasive, or simply not feasible.” (Id.) Appellant’s invention is directed to “implantable medical device systems and, in particular, to a communications network for use with implantable sensing and/or therapy delivery devices organized in a distributed, mesh network.” (Id. at 1.) Claims 5—12 and 14—182 are on appeal. Claim 5 is representative and reads as follows: 5. An implantable medical device system, comprising: multiple implantable medical devices, each of the medical devices having a node status comprising a power status of a power supply of the medical device and an operational workload of the medical device corresponding to a primary function of the medical device; means for providing a wireless communication network between the multiple medical devices via multiple communication pathways; means for receiving an adjusted network rule set; and means for automatically configuring the network wherein the configuring means comprises means for assigning network tasks to the multiple medical devices in response to the node status of each of the medical devices. (Appeal Br. 11.) 2 Claims 1,3,4, and 13 were canceled by Appellant in an Amendment filed April 16, 2015, when the Appeal Brief was filed. (Advisory Action dated Feb. 22, 2016.) 2 Appeal 2016-006291 Application 13/086,519 The following ground of rejection by the Examiner is before us on review: Claims 5—12 and 14—18 under 35 U.S.C. § 103(a) as unpatentable over Arent,3 Singh,4 Lee,5 Tran,6 and Chiu.7 DISCUSSION The Examiner finds that Arent teaches a system that includes multiple devices to be implanted within a patient that are “configured to communicate over an internal wireless network or an external computer network.” (Ans. 2.) The Examiner further finds that Arent teaches the implantable medical devices each have a power source and a microprocessor for controlling device functions and various memories, including a random access memory “for storing instructions for device operation including how the device communicates ‘network rule set’.” (Id.) The Examiner also finds that the microprocessor of Arent “contains software for implementing networks of medical devices.” (Id. at 3.) The Examiner notes that although Arent does not specifically state “that the wireless network in which the devices communicate over is a mesh network[,] it would have been obvious to make the wireless network a mesh network since the use of mesh networks for communicating between devices 3 Arent, EP 1022035 Al, published July 26, 2000. 4 Singh et al., Power-Aware Routing in Mobile Ad Hoc Networks, MobiCom ’98 Proceedings of the 4th Annual ACM/IEEE Inf 1 Conf. on Mobile Computing and Networking, 181—190 (1988) 5 Lee et al., A Workload-Based Adaptive Load-Balancing Technique for Mobile Ad Hoc Networks, IEEE Commc’ns Soc’y, 2002—2007 (2005). 6 Tran, US 2007/0273504 Al, published Nov. 29, 2007. 7 Chiu, US 2006/0092855 Al, published May 4, 2006. 3 Appeal 2016-006291 Application 13/086,519 is well known in the art as shown by Tran.” (Id.) In addition, “the [EJxaminer notes that the use of a learning process/mode during which a node within a mesh network gathers information regarding other network nodes to determine a routing scheme for communicating with other nodes is well known as shown by Chiu.” (Id. ) The Examiner further notes that “Arent does not teach monitoring a power status or an operational workload for communication purposes.” (Id.) However, the Examiner contends that such monitoring would have been obvious in light of the teachings of Singh and Lee. (Id.) The Examiner finds that Singh “teaches power-aware routing in mobile ad hoc networks which discloses looking at power-aware metrics of the node in determining which nodes will be used for routing to increase node life and network life.” (Id. at 3 (citing Singh 182, col. 1, 1st | and 187 § 5.1.) The Examiner further explains that “Singh discloses looking at power-aware metrics of the node in determining which node will be used for routing to increase node life and network life” and “that it is best to route packets through nodes that have sufficient remaining power.” (Id. at 6 (citing Singh 182, col. 1, 1st ]f.) The Examiner concludes, therefore, that “[i]t would have been obvious to one having ordinary skill in the art at the time of the invention to modify the . . . system of Arent with the teachings of Singh to include monitoring power- aware metrics at each node to determine remaining battery power in order to increase node life and network life.” (Id. at 4.) The Examiner explains that the foregoing combination meets the claim requirement of “a node status comprising a power status of a power supply” because she has interpreted “a power status of a power supply,” as used in the claims, “to include power 4 Appeal 2016-006291 Application 13/086,519 metrics related to a status of the power source of individual nodes,” “such as remaining power available.” {Id. at 6—10.) Regarding monitoring workload, the Examiner finds that Lee “teaches a workload-based adaptive load-balancing technique for mobile ad hoc networks which discloses looking at the load status/workload of each node when determining which nodes will be used for a routing protocol.” {Id. at 3.) The Examiner explains that the technique involves assessing whether a “workload is near a threshold value then additional communications using the node are not allowed . . . achieving load balance and alleviating congestion that causes long packet latency, poor packet delivery] and high routing overhead.” {Id.) The Examiner concludes that “[i]t would have been obvious to one having ordinary skill in the art at the time of the invention to further modify the system of Arent modified by Singh with the teachings of Lee to include looking at a workload of the node in order to achieve load balancing and alleviate congestion.” {Id. at 4.) We disagree with the Examiner’s factual findings concerning Singh and the Examiner’s conclusion that the combination of references renders obvious the claimed invention, particularly as to the requirement that “the configuring means comprises means for assigning network tasks to the multiple medical devices in response to the node status of each of the medical devices.” (Claim 5) (emphasis added). We note that claim 5 defines node status as comprising “a power status of a power supply of the medical device and an operation workload. . . .” Thus, the “means for assigning in response to the node status” requires assigning to be done in response to a power status of a power supply and an 5 Appeal 2016-006291 Application 13/086,519 operation workload and the claim further requires that the assigning in this way has to consider the status “of each of the medical devices.” Singh notes that “[intuitively, it is best to route packets through nodes that have sufficient remaining power (rather than through a node whose battery is on its last legs).” (Singh 182, col. 1, 1st |.) Singh states that it “show[s] that power-aware routing (built on top of a power-aware MAC protocol) can save overall energy consumption in the network and, simultaneously, increase battery life at all nodes.” {Id.) However, the foregoing is not a disclosure of a network that has a configuring means that includes a means for assigning network tasks in response to a power status of each of the devices. Singh section 5.1 also does not disclose this. That section states: Based on the simulations, we can conclude that using power- aware metrics to find routes is very beneficial because the difference in battery consumption between various nodes is reduced. This typically means longer network life and longer time to node failure. (Singh 187.) Singh provides a discussion of “several power-aware metrics that do result in energy-efficient routes” {id. at 183—185), including one “that reflects] a battery’s remaining lifetime” (id. at 184 (see metric “4. Minimize Cost/Packet”). However, Singh notes that these metrics “express our intuition about conserving energy in the network by selecting routes carefully” and that metrics 3—5, which includes metric 4 that incorporates consideration of battery life, have not been implemented yet. {Id. at 185.) And even if Singh can be considered to have implemented metric 4, the Examiner has not directed us to where, and we do not discern that, there is a 6 Appeal 2016-006291 Application 13/086,519 disclosure of assigning network tasks to multiple medical devices utilizing a node status of each medical device that comprises a power status of a power supply. (See also Reply Br. 4 noting that nothing in Singh discloses such assignment.) Furthermore, Singh details its power-aware protocol for its ad hoc network, and it also does not describe monitoring a power status of a power supply, much less in determining assigning network tasks based on the power status of the power supply. (Singh at 185—186.) In this protocol, the conditions under which nodes power off are stated to be: • A node powers off if it is overhearing a transmission and does not have a packet to transmit, • If at least one neighbor is transmitting and at least one neighbor is receiving a transmission, a node may power off. This is because, even if the node has a packet to transmit, it cannot do so for fear of interfering with its neighbor’s reception. • If all of a node’s neighbors neighbors are transmitting (and the node is not a receiver), it powers itself off. (Id. at 185.) “[T]he examiner bears the initial burden, on review of the prior art. . . , of presenting a prima facie case of unpatentability.” In re Oetiker, 977 F.2d 1443, 1445 (Fed. Cir. 1992). In sum, the Examiner has not pointed out to us where, nor do we discern that, Singh teaches a disclosure of a network that has a configuring means that includes a means for assigning network tasks in response to a power status of power supply of each of the devices. Furthermore, because the Examiner has not identified any other teaching of this limitation in the references, we do not sustain the Examiner’s obviousness rejection. 7 Appeal 2016-006291 Application 13/086,519 SUMMARY We reverse the rejection of claims 5—12 and 14—18 under 35 U.S.C. § 103(a) as unpatentable over Arent, Singh, Lee, Tran, and Chiu. REVERSED 8 Copy with citationCopy as parenthetical citation